Arterial homograft and medical therapy in pseudoaneurysm of infrarenal aorta concomitant with recurrent right ventricular thrombus in Behcet's disease.

Saudi Med J

Department of Cardiovascular Surgery, Rajaie Hospital and Research Center, Adjacent to Mellat Park, Vali-Asr Ave. PO Box 1996911151, Tehran, Iran.

Published: September 2006

Pseudoaneurysm of the infrarenal aorta due to Behcet s disease is very rare. We report a case of pseudoaneurysm associated with Behcet s disease in a 17-year-old boy with a recurrent right ventricular thrombus successfully treated with revascularization using arterial homograft patch. Echocardiography examination revealed a right ventricular mass, thought to be a thrombus in an unusual location. Postoperatively, the findings of the pathologic examination confirmed the mass as a thrombus. When the patient was subsequently re-admitted to the emergency unit with complaints of severe abdominal pain, fever, fatigue, sinus tachycardia, and a pulsating and tender abdominal mass, a right ventricular thrombus and a large pseudoaneurysm of the abdominal aorta were found on echocardiography and angiography. The patient underwent resection of the aortic aneurysm and aortoplasty, using arterial homograft patch, and received immunosuppressive and anticoagulation therapy. The thrombus of the right ventricle disappeared 4 months later. This case indicates that a right ventricular thrombosis in Behcet s disease may be managed by medical therapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

arterial homograft
12
ventricular thrombus
12
behcet disease
12
medical therapy
8
pseudoaneurysm infrarenal
8
infrarenal aorta
8
recurrent ventricular
8
homograft patch
8
thrombus
6
ventricular
5

Similar Publications

Objectives: To describe the workflow and value of three-dimensional rotational angiography (3DRA) in percutaneous pulmonary valve implantation (PPVI).

Background: 3DRA offers visualization of the entire topography in the chest and may enhance safety and reduce the risk for complications in PPVI through improved pre-procedural planning and per-procedural guidance.

Methods: All PPVI procedures with the use of 3DRA performed between August 2011 and December 2022 were reviewed.

View Article and Find Full Text PDF

Localized COUP-TFII pDNA Delivery Modulates Stem/Progenitor Cell Differentiation to Enhance Endothelialization and Inhibit Calcification of Decellularized Allografts.

Adv Sci (Weinh)

December 2024

State key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, Key Laboratory of Bioactive Materials (Ministry of Education), College of Life Sciences, Nankai University, Tianjin, 300071, China.

Decellularized allografts have emerged as promising candidates for vascular bypass grafting, owing to their inherent bioactivity and minimal immunogenicity. However, graft failure that results from suboptimal regeneration and pathological remodeling has hindered their clinical adoption. Recent advances in vascular biology highlight the pivotal role of COUP-TFII in orchestrating endothelial identity, angiogenesis, safeguarding against atherosclerosis, and mitigating vascular calcification.

View Article and Find Full Text PDF

Objectives: Ruptured mycotic pseudoaneurysms are rare, yet devastating complications that can prove challenging to manage. In immunocompromised populations, highly virulent organisms such as Gemella morbillorum can be especially difficult to combat. Here, we outline our approach to temporizing maneuvers in an emergent setting and definitive revascularization in a 27-year-old with a ruptured mycotic iliac artery pseudoaneurysm from necrosis of her kidney and pancreas allografts.

View Article and Find Full Text PDF

Objectives: The use of homograft for vascular reconstruction is a common practice in infective setting or to prevent aneurysmal dilation over the time. The use of fresh arterial homograft is conversely rarely reported.

Methods: We report a case about the use of fresh arterial homograft as a substitute of carotid intra-stent stenosis.

View Article and Find Full Text PDF

Indications and Outcomes with Liver Retransplantation in 2025.

Dig Dis Sci

November 2024

Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Michigan, 3912 Taubman Center, Ann Arbor, MI, 48109-0362, USA.

Article Synopsis
  • * The rates of primary non-function (PNF) have significantly decreased, but PNF and complications like hepatic artery thrombosis are still the main reasons for urgent retransplantation.
  • * Survival rates for retransplantation are generally lower compared to primary transplants, and factors such as high MELD scores and renal failure can worsen outcomes, leading centers to prefer younger donor organs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!